{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uaz:UAZ05409",
      "entity_text" : "epidermal growth factor receptor-tyrosine",
      "entity_type" : "protein"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "pubchem:123631",
      "entity_text" : "gefitinib",
      "entity_type" : "simple_chemical"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Small molecules such as epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) like erlotinib, gefitinib and lapatinib have been demonstrated to have the ability to cross the blood-brain barrier (BBB).",
  "reading_complete" : "2020-08-02T18:56:22Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-02T18:54:26Z",
  "trigger" : "inhibitors",
  "evidence" : [ "epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs) like erlotinib, gefitinib" ],
  "pmc_id" : "3542167",
  "score" : 0
}